Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models.
Ludwig DS, Apovian CM, Aronne LJ, Astrup A, Cantley LC, Ebbeling CB, Heymsfield SB, Johnson JD, King JC, Krauss RM, Taubes G, Volek JS, Westman EC, Willett WC, Yancy WS Jr, Friedman MI. Ludwig DS, et al. Among authors: aronne lj. Eur J Clin Nutr. 2022 Sep;76(9):1209-1221. doi: 10.1038/s41430-022-01179-2. Epub 2022 Jul 28. Eur J Clin Nutr. 2022. PMID: 35896818 Free PMC article. Review.
HCA efficiency.
Heymsfield SB, Aronne LJ, Blackburn GL. Heymsfield SB, et al. Among authors: aronne lj. Diabetes Obes Metab. 2004 Nov;6(6):458-9; author reply 460-1. doi: 10.1111/j.1462-8902.2004.00423.x. Diabetes Obes Metab. 2004. PMID: 15479223 No abstract available.
Ten putative contributors to the obesity epidemic.
McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, Benca RM, Biggio J, Boggiano MM, Eisenmann JC, Elobeid M, Fontaine KR, Gluckman P, Hanlon EC, Katzmarzyk P, Pietrobelli A, Redden DT, Ruden DM, Wang C, Waterland RA, Wright SM, Allison DB. McAllister EJ, et al. Among authors: aronne lj. Crit Rev Food Sci Nutr. 2009 Nov;49(10):868-913. doi: 10.1080/10408390903372599. Crit Rev Food Sci Nutr. 2009. PMID: 19960394 Free PMC article. Review.
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study.
Aronne LJ, Tonstad S, Moreno M, Gantz I, Erondu N, Suryawanshi S, Molony C, Sieberts S, Nayee J, Meehan AG, Shapiro D, Heymsfield SB, Kaufman KD, Amatruda JM. Aronne LJ, et al. Int J Obes (Lond). 2010 May;34(5):919-35. doi: 10.1038/ijo.2010.21. Epub 2010 Feb 16. Int J Obes (Lond). 2010. PMID: 20157323 Clinical Trial.
New drug targets for the treatment of obesity.
Powell AG, Apovian CM, Aronne LJ. Powell AG, et al. Among authors: aronne lj. Clin Pharmacol Ther. 2011 Jul;90(1):40-51. doi: 10.1038/clpt.2011.82. Epub 2011 Jun 8. Clin Pharmacol Ther. 2011. PMID: 21654742 Review.
Emerging pharmacotherapy for obesity.
Aronne LJ, Powell AG, Apovian CM. Aronne LJ, et al. Expert Opin Emerg Drugs. 2011 Sep;16(3):587-96. doi: 10.1517/14728214.2011.609168. Epub 2011 Aug 12. Expert Opin Emerg Drugs. 2011. PMID: 21834735 Review.
Zonisamide for weight reduction in obese adults.
Apovian CM, Aronne LJ. Apovian CM, et al. Among authors: aronne lj. JAMA. 2013 Aug 14;310(6):637-8. doi: 10.1001/jama.2013.101049. JAMA. 2013. PMID: 23942682 No abstract available.
Weight loss treatment in obese adults--reply.
Apovian CM, Aronne LJ. Apovian CM, et al. Among authors: aronne lj. JAMA. 2013 Dec 18;310(23):2568. doi: 10.1001/jama.2013.282261. JAMA. 2013. PMID: 24347001 No abstract available.
186 results